Translational Development Acquisition

TDAC · NASDAQ

$10.81+$0.00 (+0.00%)TodayMarket closed · Oct 23, 7:32 PM ET

Prev close $10.81

About TDAC

Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2024-12-23. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm has neither engaged in any operations nor generated any revenues.

Employees: 0
Headquarters: New York City, New York
Listed: Dec 23, 2024
Sector: N/A
Industry: N/A

Leadership

Translational Development Acquisition executives
Name	Title	Since	Age
Michael Hoffman	—	2022	74
Avanindra Das	—	—	39
Christopher Jarratt	—	—	66
Curtis Keith	—	—	54
Matthew Kestenbaum	—	—	34
E. Premkumar Reddy	—	—	80

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.